301 related articles for article (PubMed ID: 14524533)
1. Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma.
Carlinfante G; Vassiliou D; Svensson O; Wendel M; Heinegård D; Andersson G
Clin Exp Metastasis; 2003; 20(5):437-44. PubMed ID: 14524533
[TBL] [Abstract][Full Text] [Related]
2. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases.
Ibrahim T; Leong I; Sanchez-Sweatman O; Khokha R; Sodek J; Tenenbaum HC; Ganss B; Cheifetz S
Clin Exp Metastasis; 2000; 18(3):253-60. PubMed ID: 11315099
[TBL] [Abstract][Full Text] [Related]
3. Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.
Zhang L; Hou X; Lu S; Rao H; Hou J; Luo R; Huang H; Zhao H; Jian H; Chen Z; Liao M; Wang X
Lung Cancer; 2010 Jan; 67(1):114-9. PubMed ID: 19376608
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of bone sialoprotein in bone metastases compared with visceral metastases in human breast and prostate cancers.
Waltregny D; Bellahcène A; de Leval X; Florkin B; Weidle U; Castronovo V
J Bone Miner Res; 2000 May; 15(5):834-43. PubMed ID: 10804012
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers.
Gillespie MT; Thomas RJ; Pu ZY; Zhou H; Martin TJ; Findlay DM
Int J Cancer; 1997 Dec; 73(6):812-5. PubMed ID: 9399657
[TBL] [Abstract][Full Text] [Related]
6. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J
Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
[TBL] [Abstract][Full Text] [Related]
8. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases.
Bellahcène A; Castronovo V
Bull Cancer; 1997 Jan; 84(1):17-24. PubMed ID: 9180854
[TBL] [Abstract][Full Text] [Related]
9. Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.
Wu G; Guo JJ; Ma ZY; Wang J; Zhou ZW; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2010-7. PubMed ID: 25973097
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of bone sialoprotein in clear cell renal carcinoma.
Righi L; Bollito E; Ceppi P; Mirabelli D; Tavaglione V; Chiusa L; Porpiglia F; Brunelli M; Martignoni G; Terrone C; Papotti M
Anticancer Res; 2013 Jun; 33(6):2679-87. PubMed ID: 23749927
[TBL] [Abstract][Full Text] [Related]
11. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development.
Bellahcene A; Kroll M; Liebens F; Castronovo V
J Bone Miner Res; 1996 May; 11(5):665-70. PubMed ID: 9157781
[TBL] [Abstract][Full Text] [Related]
12. Bone sialoprotein, matrix metalloproteinase 2, and alpha(v)beta3 integrin in osteotropic cancer cell invasion.
Karadag A; Ogbureke KU; Fedarko NS; Fisher LW
J Natl Cancer Inst; 2004 Jun; 96(12):956-65. PubMed ID: 15199115
[TBL] [Abstract][Full Text] [Related]
13. SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2.
Xu M; Jiang H; Wang H; Liu J; Liu B; Guo Z
Oncol Rep; 2018 Aug; 40(2):726-736. PubMed ID: 29917166
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.
Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW
Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612
[TBL] [Abstract][Full Text] [Related]
15. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
Reinholz MM; Iturria SJ; Ingle JN; Roche PC
Breast Cancer Res Treat; 2002 Jun; 74(3):255-69. PubMed ID: 12206515
[TBL] [Abstract][Full Text] [Related]
16. Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells.
Barnes GL; Javed A; Waller SM; Kamal MH; Hebert KE; Hassan MQ; Bellahcene A; Van Wijnen AJ; Young MF; Lian JB; Stein GS; Gerstenfeld LC
Cancer Res; 2003 May; 63(10):2631-7. PubMed ID: 12750290
[TBL] [Abstract][Full Text] [Related]
17. Sustained delivery and efficacy of polymeric nanoparticles containing osteopontin and bone sialoprotein antisenses in rats with breast cancer bone metastasis.
Elazar V; Adwan H; Bäuerle T; Rohekar K; Golomb G; Berger MR
Int J Cancer; 2010 Apr; 126(7):1749-60. PubMed ID: 19739076
[TBL] [Abstract][Full Text] [Related]
18. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
Diel IJ; Solomayer EF; Seibel MJ; Pfeilschifter J; Maisenbacher H; Gollan C; Pecherstorfer M; Conradi R; Kehr G; Boehm E; Armbruster FP; Bastert G
Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
[TBL] [Abstract][Full Text] [Related]
19. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone.
Wang L; Song L; Li J; Wang Y; Yang C; Kou X; Xiao B; Zhang W; Li L; Liu S; Wang J
Cancer Sci; 2019 Oct; 110(10):3157-3172. PubMed ID: 31432600
[TBL] [Abstract][Full Text] [Related]
20. Bone sialoprotein mRNA expression and ultrastructural localization in fetal porcine calvarial bone: comparisons with osteopontin.
Chen J; McKee MD; Nanci A; Sodek J
Histochem J; 1994 Jan; 26(1):67-78. PubMed ID: 8169152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]